Phase 1 Dose Escalation Trial of ZM008, an Anti-LLT1 Antibody, as Single Agent Followed by Combination With Toripalimab in Patients With Advanced Solid Tumors
NCT06451497 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Zumutor Biologics Inc. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Zumutor Biologics Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Zumutor Biologics Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Zumutor Biologics Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Zumutor Biologics Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.